Substance P Creates Pain Feedback Loop in Facial Pain by Activating Glial Cells Through RAS/RAF/MEK Pathway
Substance P upregulates its own NK-1 receptor in satellite glial cells via the PKA/RAS-RAF-MEK-ERK pathway, creating a positive feedback loop that amplifies inflammatory orofacial pain.
Quick Facts
What This Study Found
Substance P upregulated NK-1 receptor expression in trigeminal satellite glial cells via the PKA/RAS-B-RAF-MEK-ERK pathway. NK-1R antagonist, MEK inhibitor, RAF inhibitor, and PKA inhibitor all reduced NK-1 expression and pain behavior, while PKC inhibitor did not.
Key Numbers
SP activated ERK1/2, PKA, PKC via NK1R; RAS/B-RAF-MEK-ERK pathway identified as key mediator of glial-mediated pain.
How They Did This
In vivo CFA-induced inflammatory orofacial pain model in rats. In vitro SGC cultures treated with substance P and pathway inhibitors. Pre-injection of inhibitors into trigeminal ganglion. qPCR, Western blot, and behavioral pain assessment.
Why This Research Matters
Understanding the molecular feedback loop that amplifies chronic facial pain could lead to more targeted treatments. Multiple points in this pathway (NK-1R, RAF, MEK, PKA) represent potential drug targets for conditions like trigeminal neuralgia and TMJ disorders.
The Bigger Picture
Chronic pain is increasingly understood as involving glial cell activation, not just neuronal signaling. This substance P feedback loop in satellite glial cells provides a mechanistic target for breaking the pain amplification cycle that drives chronic orofacial conditions.
What This Study Doesn't Tell Us
Rat model of orofacial pain may not perfectly replicate human trigeminal pain conditions. In vitro SGC cultures may behave differently than in vivo. Some inhibitors used (e.g., sorafenib) have broad activity and clinical side effects.
Questions This Raises
- ?Could targeting the RAS/RAF/MEK pathway in glial cells specifically treat chronic facial pain?
- ?Is this SP-NK-1R feedback loop also present in other chronic pain conditions?
- ?Would combination therapy targeting multiple pathway nodes provide better pain relief?
Trust & Context
- Key Stat:
- Positive feedback substance P upregulates its own receptor via RAS/RAF/MEK/ERK in glial cells, amplifying pain
- Evidence Grade:
- Well-designed animal study with complementary in vivo and in vitro evidence and multiple pathway inhibitor controls confirming specificity.
- Study Age:
- Published in 2020. Glial cell involvement in pain amplification continues to be an active research area.
- Original Title:
- Activation of the RAS/B-RAF-MEK-ERK pathway in satellite glial cells contributes to substance p-mediated orofacial pain.
- Published In:
- The European journal of neuroscience, 51(11), 2205-2218 (2020)
- Authors:
- Zhang, Yan-Yan, Song, Ning, Liu, Fei(3), Lin, Jiu, Liu, Meng-Ke, Huang, Chao-Lan, Liao, Da-Qing, Zhou, Cheng, Wang, Hang, Shen, Jie-Fei
- Database ID:
- RPEP-05236
Evidence Hierarchy
Frequently Asked Questions
What is a positive feedback loop in pain?
In this case, substance P makes glial cells produce more of the receptor that substance P binds to, which means more substance P signaling, which produces even more receptors — a self-amplifying cycle that intensifies pain.
What are satellite glial cells?
Satellite glial cells surround nerve cell bodies in ganglia (nerve clusters). They were once thought to be passive support cells, but are now known to actively influence pain processing and can amplify or dampen pain signals.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05236APA
Zhang, Yan-Yan; Song, Ning; Liu, Fei; Lin, Jiu; Liu, Meng-Ke; Huang, Chao-Lan; Liao, Da-Qing; Zhou, Cheng; Wang, Hang; Shen, Jie-Fei. (2020). Activation of the RAS/B-RAF-MEK-ERK pathway in satellite glial cells contributes to substance p-mediated orofacial pain.. The European journal of neuroscience, 51(11), 2205-2218. https://doi.org/10.1111/ejn.14619
MLA
Zhang, Yan-Yan, et al. "Activation of the RAS/B-RAF-MEK-ERK pathway in satellite glial cells contributes to substance p-mediated orofacial pain.." The European journal of neuroscience, 2020. https://doi.org/10.1111/ejn.14619
RethinkPeptides
RethinkPeptides Research Database. "Activation of the RAS/B-RAF-MEK-ERK pathway in satellite gli..." RPEP-05236. Retrieved from https://rethinkpeptides.com/research/zhang-2020-activation-of-the-rasbrafmekerk
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.